Circadian Technologies (Opthea)
Participant:
Megan Baldwin
Dr. Megan Baldwin is CEO/Managing Director of Circadian Technologies (Opthea) and has over 19 years of experience in preclinical and clinical development of therapies for cancer and eye diseases.